A Platform Study for solId orgaN CancERs

Sex: All

Ages: 16 Years – 100 Years

Healthy volunteers: 1

Enrollment: 2000

Sponsor: University of Liverpool

Summary

Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.

Eligibility Criteria

Inclusion Criteria:Biopsy or surgical resection as standard of careExclusion Criteria:Refusal or inability to consent, paediatric patients

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05650125). StuddyBuddy aggregates publicly available trial information.